Jean-Sébastien Garrigue
Geen lopende functies
Profiel
Jean-Sébastien Garrigue worked as the Director of Research & Pharmaceutical Development at Novagali Pharma SA from 2009 to 2011.
He holds an MBA from Université Paris 1.
Panthéon-Sorbonne, a doctorate, and a graduate degree from Université de Paris XI Paris Sud.
Eerdere bekende functies van Jean-Sébastien Garrigue
| Bedrijven | Functie | Einde |
|---|---|---|
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jean-Sébastien Garrigue
| Université Paris 1 Panthéon-Sorbonne | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
